Zejula (Niraparib) Side Effects: A Comprehensive Guide for Ovarian Cancer Patients

Understanding Zejula (Niraparib) and Its Side Effects Zejula, with the active ingredient niraparib, is a crucial prescription medication used in the maintenance treatment of certain types of ovarian cancer. It plays a significant role after initial platinum-based chemotherapy has shown positive results. While Zejula offers a beacon of hope for many patients, it's essential to be aware of its potential side effects. This guide aims to provide a clear, practical overview for Indian patients, detailing common, mild, and serious adverse reactions, along with management strategies and when to seek medical attention. What is Zejula and How Does It Work? Zejula belongs to a class of drugs known as PARP inhibitors. These drugs work by targeting cancer cells that have specific genetic mutations, such as BRCA mutations, which are common in ovarian cancer. By inhibiting PARP enzymes, Zejula prevents cancer cells from repairing their damaged DNA, ultimately leading to their death. It is prescribed for adults with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer that has responded to initial platinum-based chemotherapy. It is also used for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with a BRCA gene mutation. Common Side Effects of Zejula Like most medications, Zejula can cause side effects. The most frequently reported side effects in clinical studies include: Low blood cell counts: This is a significant side effect and can affect platelets (thrombocytopenia), red blood cells (anemia), and white blood cells (neutropenia). Low platelet counts can increase the risk of bleeding, while low red blood cell counts can lead to fatigue and shortness of breath. Reduced white blood cell counts can make you more susceptible to infections. Fatigue: Feeling unusually tired or lacking energy is common. Nausea: A feeling of sickness in the stomach. Constipation: Difficulty in passing stools. Vomiting: Expelling the contents of the stomach. Headache: Pain in the head. Loss of appetite: Reduced desire to eat. Abdominal pain: Discomfort in the stomach area. Shortness of breath: Difficulty in breathing. High blood pressure (hypertension): An increase in blood pressure. Decreased platelet count: This can lead to bruising or bleeding more easily. Decreased white blood cell count: This can increase the risk of infection. Decreased red blood cell count: This can cause fatigue and weakness. It's important to note that not everyone will experience these side effects, and their severity can vary. Your doctor will monitor your blood counts regularly throughout your treatment. Mild Side Effects and Management Many of the common side effects are mild and can often be managed with supportive care. For instance: For nausea and vomiting: Your doctor may prescribe anti-nausea medications. Eating smaller, more frequent meals and avoiding strong-smelling or greasy foods can also help. For constipation: Increasing fluid intake, consuming fiber-rich foods, and engaging in light physical activity can be beneficial. Your doctor might also suggest a mild laxative if needed. For fatigue: Pacing yourself, getting adequate rest, and light exercise (as advised by your doctor) can help manage fatigue. For headache: Over-the-counter pain relievers (like paracetamol, if approved by your doctor) may be used. Always discuss any persistent or bothersome mild side effects with your healthcare provider. Serious Side Effects of Zejula While less common, Zejula can cause serious side effects that require immediate medical attention. It is crucial to be aware of these and report them to your doctor promptly. Bone Marrow Suppression: This is a serious concern where Zejula can significantly reduce the production of blood cells in the bone marrow. This can lead to severe anemia, thrombocytopenia, and neutropenia, increasing the risk of life-threatening infections and bleeding. In rare cases, prolonged bone marrow suppression can be associated with the development of other blood cancers like Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Studies have shown these can occur months to years after starting Zejula. Cardiovascular Effects: Zejula can affect heart function. Monitoring blood pressure and heart rate is essential, especially during the initial months of treatment. Symptoms like chest pain, palpitations, or significant changes in blood pressure or heart rate should be reported immediately. Severe Allergic Reactions: Although rare, severe allergic reactions (anaphylaxis) can occur. Symptoms include swelling of the face, lips, tongue, or throat, difficulty breathing, hives, or a severe rash. If you experience any of these, call emergency services (like 108 or 112 in India) immediately. Pulmonary Toxicity: Some patients may experience lung problems, such as pneumonitis (inflammation of the lungs), which can cause shortness of breath, cough, and fever. Important Precautions and Interactions Pregnancy and Breastfeeding: Zejula can harm a developing fetus and is not safe to take while breastfeeding. If you are able to become pregnant, you will need to use effective contraception during treatment and for a period after treatment ends, as advised by your doctor. Discuss breastfeeding options with your doctor before starting Zejula. Tartrazine (FD&C Yellow No. 5) Allergy: Zejula capsules contain tartrazine, a dye that can cause allergic reactions in sensitive individuals. If you have a known allergy to tartrazine, inform your doctor. Drug Interactions: Always inform your doctor about all the medications, supplements, and herbal products you are taking to avoid potential interactions with Zejula. Hair Loss and Zejula Hair loss can be a distressing side effect of chemotherapy. It's important to note that after chemotherapy, hair regrowth typically takes 3-6 months. Since Zejula treatment often starts within 8-12 weeks after chemotherapy concludes, any hair loss experienced during this overlap period might be a

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.